← Product Code [FMF](/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/FMF) · K081241 # WEIGAO EMPTY CARTRIDGE SYRINGE (K081241) _Shandong Weigao Group Medical Polymer Co., Ltd. · FMF · Sep 8, 2008 · General Hospital · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/FMF/K081241 ## Device Facts - **Applicant:** Shandong Weigao Group Medical Polymer Co., Ltd. - **Product Code:** [FMF](/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/FMF.md) - **Decision Date:** Sep 8, 2008 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 880.5860 - **Device Class:** Class 2 - **Review Panel:** General Hospital - **Attributes:** Therapeutic ## Indications for Use Weigao Disposable Empty Cartridge Syringe is intended for use in the withdrawal and administration of fluid in accordance with the best judgment of the physician. ## Device Story The Weigao Disposable Empty Cartridge Syringe is a manual, piston-style syringe consisting of a hollow glass barrel and a movable plunger. It is designed for the withdrawal and administration of fluids. The device is intended for use by healthcare professionals in clinical settings. It does not contain drugs, biological products, or antimicrobial/antithrombotic ingredients. The device is not for life-supporting, life-sustaining, or implantable use. Operation is entirely manual; the physician controls the fluid volume and delivery based on clinical judgment. ## Clinical Evidence No clinical data provided. Evidence consists of bench testing and biocompatibility testing. Performance bench tests were conducted in accordance with ISO 11040-4, ISO 7886-1, and ISO 9626. Biocompatibility testing was conducted in accordance with ISO 10993. ## Technological Characteristics Materials: Glass barrel, movable plunger. Design: Piston syringe, 1 ml Slim model with scale marks and fixed 27G needle. Energy source: Manual. Sterilization: Not specified. Standards: ISO 10993 (biocompatibility), ISO 11040-4, ISO 7886-1, ISO 9626 (performance). ## Regulatory Identification A piston syringe is a device intended for medical purposes that consists of a calibrated hollow barrel and a movable plunger. At one end of the barrel there is a male connector (nozzle) for fitting the female connector (hub) of a hypodermic single lumen needle. The device is used to inject fluids into, or withdraw fluids from, the body. ## Predicate Devices - Empty Sterile Carpuject® Cartridge ([K820164](/device/K820164.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ K08/241 1 of 3 SEP - 8 2008 # Attachment IV 510(k) Summary This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92. The Assigned 510(k) Number is: ## 1. Applicant Device Information Trade/Proprietary Name: Weigao Disposable Empty Cartridge Syringe Common Name: Syringe, Piston Classification Name: Syringe, Piston Device Class: II Product Code: FMF Regulation Number: 880.5860 Intended Use: Weigao Disposable Empty Cartridge Syringe is intended for use in the withdrawal and administration of fluid in accordance with the best judgment of the physician. #### 2. Submitter Information #### Establishment Registration Name: ShanDong WeiGao Group Medical Polymer Products Co., LTD No.312, Shichang Road Weihai, Shandong, China, 264209 Contact Person of the Submission: Ms. Diana Hong: Mr. Eric Chen Suite 8D, Zhongxin Zhongshan Mansion, No.19, Lane 999, South Zhong Shan No.2 Road Shanghai, China 20020 Phone: +86-21-64264467 x 152 Fax: +86-21-64264468 x 809 Email: Diana.hong@mid-link.net Eric.chen@mid-link.net Shanghai MIDLINK Business Cosulting Co., Ltd {1}------------------------------------------------ 208/241 2 of 3 Premarket Notification 510(k) Submission-510(k) Summary Report No .: A20071011 ### 3. Predicate Device Predicate device K820164 Trade/Proprietary Name: Empty Sterile Carpuject® Cartridge Common/Usual Name: Piston syringe. Classification Name: Syringe, piston Submitter Name: Hospira, Inc. Address: D-389, Bldg. H2 275 N. Field Drive Lake Forest, IL 60045 Attn: Diane Rennpferd Phone: (224) 212-5452 Fax: (224) 212-5401 #### 4. Device Description The subject device of Weigao Disposable Empty Cartridge Syringe is an empty cartridge syringe that consists of a hollow barrel and a movable plunger. The syringes are designed for manual use. The applicant syringe's main components are made of glass. #### Specifications: Model 1 ml Slim with scale marks (fixed with Needle 27G), The applicant devices don't contain drug or biological products. They are not for life-supporting or life-sustaining. It is not for implant. No antimicrobial or antithrombotic ingredient is applied on the applicant device. No chemical for the enhancement of its clinical performance is applied on or incorporated into applicant device. No specific drug or biologic is applied with the applicant device. #### 5. Test Data The biocompatibility tests are conducted following ISO 10993 as Appendix 1 Biocompatibility Shanghai MIDLINK Business Cosulting Co., Ltd X2 {2}------------------------------------------------ Test. The performance bench tests follows ISO 11040-4, ISO 7886-1, ISO 9626 are provided as Appendix 2 Performance Test. #### 6. Substantially Equivalence The applicant device is Substantially Equivalent (SE) to the predicate device in terms of Effectiveness and Safety. Shanghai MIDLINK Business Cosulting Co., Ltd . X3 {3}------------------------------------------------ Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a stylized eagle with three stripes forming its body and wings. The eagle is facing to the right. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the eagle. SEP - 8 2008 Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 ShanDong WeiGao Group Medical Polymer Products Company, Limited C/O Ms. Diana Hong General Manager Shanghai Mid-Link Business Consulting Company, Limited Suite 8D, Zhongxin Zhongshan Mansion No. 19, Lane 999, Zhong Shan No. 2 Road(S) Shanghai CHINA 200030 Re: K081241 Trade/Device Name: WeiGao Disposable Empty Cartridge Syringe Regulation Number: 21 CFR 880.5860 Regulation Name: Piston Syringe Regulatory Class: II Product Code: FMF Dated: July 28, 2008 Received: July 30, 2008 Dear Ms. Hong: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {4}------------------------------------------------ Page 2 - Ms. Hong Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely yours, *MAnuels-Lendims for //* Chiu Lin. Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health {5}------------------------------------------------ # Indications for Use 510(k) Number: __________________ Device Name: _________________________________________________________________________________________________________________________________________________________________ Indications for Use: Weigao Disposable Empty Cartridge Syringe is intended for use in the withdrawal and administration of fluid in accordance with the best judgment of the physician. Prescription Use __ √ (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Anthony D. autor (Division Sign-Off) Division of Anesthesiology, General Hospital Infection Control, Dental Devices Page 1_ of ________________________________________________________________________________________________________________________________________________________________________ l 510(k) Number: K �8124 1 --- **Source:** [https://fda.innolitics.com/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/FMF/K081241](https://fda.innolitics.com/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/FMF/K081241) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com